Related references
Note: Only part of the references are listed.Associations between subclinical thyroid disease and metabolic syndrome
Chih-Yuan Wang et al.
ENDOCRINE JOURNAL (2012)
Cuprizone-induced demyelination in the rat cerebral cortex and thyroid hormone effects on cortical remyelination
Lucas Silvestroff et al.
EXPERIMENTAL NEUROLOGY (2012)
The T3-induced gene KLF9 regulates oligodendrocyte differentiation and myelin regeneration
Jason C. Dugas et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2012)
The Effect of Thyroid Disorders on Lipid Levels and Metabolism
Leonidas H. Duntas et al.
MEDICAL CLINICS OF NORTH AMERICA (2012)
Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis A case-control study
Robert Zivadinov et al.
NEUROIMAGE (2012)
Interferon-β and serum 25-hydroxyvitamin D interact to modulate relapse risk in MS
Niall Stewart et al.
NEUROLOGY (2012)
Triiodothyronine Administration Ameliorates the Demyelination/Remyelination Ratio in a Non-Human Primate Model of Multiple Sclerosis by Correcting Tissue Hypothyroidism
G. D'Intino et al.
JOURNAL OF NEUROENDOCRINOLOGY (2011)
Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis
Bianca Weinstock-Guttman et al.
JOURNAL OF NEUROINFLAMMATION (2011)
Inter-dependence of vitamin D levels with serum lipid profiles in multiple sclerosis
Bianca Weinstock-Guttman et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Simvastatin as add-on therapy to interferon beta-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial
Per Soelberg Sorensen et al.
LANCET NEUROLOGY (2011)
The immune system in atherosclerosis
Goran K. Hansson et al.
NATURE IMMUNOLOGY (2011)
Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions
E. C. Tallantyre et al.
NEUROLOGY (2011)
Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids
Rolf Jorde et al.
PROGRESS IN LIPID RESEARCH (2011)
Ultrasensitive Quantification of Serum Vitamin D Metabolites Using Selective Solid-Phase Extraction Coupled to Microflow Liquid Chromatography and Isotope-Dilution Mass Spectrometry
Xiaotao Duan et al.
ANALYTICAL CHEMISTRY (2010)
The Combination of Interferon-Beta and HMG-CoA Reductase Inhibition in Multiple Sclerosis: Enthusiasm Lost too Soon?
Johann Sellner et al.
CNS NEUROSCIENCE & THERAPEUTICS (2010)
Lipid lowering with thyroid hormone and thyromimetics
Bo Angelin et al.
CURRENT OPINION IN LIPIDOLOGY (2010)
Validation of a Self-Report Comorbidity Questionnaire for Multiple Sclerosis
Myles Horton et al.
NEUROEPIDEMIOLOGY (2010)
Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis
R. A. Marrie et al.
NEUROLOGY (2010)
Paraoxonase 1 activity in different types of multiple sclerosis
A. Jamroz-Wisniewska et al.
MULTIPLE SCLEROSIS JOURNAL (2009)
COMBINING BETA INTERFERON AND ATORVASTATIN MAY INCREASE DISEASE ACTIVITY IN MULTIPLE SCLEROSIS
Silva Markovic-Plese et al.
NEUROLOGY (2009)
Effect of statins on clinical and molecular responses to intramuscular interferon beta-1a
R. A. Rudick et al.
NEUROLOGY (2009)
Smoke exposure increases the risk for multiple sclerosis
P. Sundstrom et al.
EUROPEAN JOURNAL OF NEUROLOGY (2008)
Structural modifications of HDL and functional consequences
G Ferretti et al.
ATHEROSCLEROSIS (2006)
Environmental tobacco smoke and risk of respiratory cancer and chronic obstructive pulmonary disease in former smokers and never smokers in the EPIC prospective study
P Vineis
BRITISH MEDICAL JOURNAL (2005)
Interferon-β treatment decreases cholesterol plasma levels in multiple sclerosis patients
VB Morra et al.
NEUROLOGY (2004)
Oral simvastatin treatment in relapsing-remitting multiple sclerosis
T Vollmer et al.
LANCET (2004)
Normal timing of oligodendrocyte development depends on thyroid hormone receptor alpha 1 (TRα1)
N Billon et al.
EMBO JOURNAL (2002)
Blood cholesterol and MRI activity in first clinical episode suggestive of multiple sclerosis
F Giubilei et al.
ACTA NEUROLOGICA SCANDINAVICA (2002)
Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS
R Zivadinov et al.
NEUROLOGY (2001)
Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis.
LD Jacobs et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Interferon beta 1a therapy changes lipoprotein metabolism in patients with multiple sclerosis
A Sena et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2000)
Share Paper
